公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

5,848 记录

产品持有公司班级有效性
Anti-Chlamydia trachomatis MIF 1 (IgM)10338930329EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV28/04/2035
Anti-Citomegalovírus IgG10338930130EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV13/10/2034
Anti-Citomegalovírus IgG avidez10338930117EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV01/09/2034
Anti-Citomegalovírus IgM10338930126EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV13/10/2034
Anti-Citomegalovírus em LCR (IgG)10338930128EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV13/10/2034
Anti-D IgG Mono-Type80134860246GRIFOLS BRASIL LTDAIV10/07/2027
Anti-Fya Mono-Type80134860244GRIFOLS BRASIL LTDAIV10/07/2027
Anti-Fya for DG Gel e Anti-Fyb for DG Gel80134860249GRIFOLS BRASIL LTDAIV10/07/2027
Anti-Fyb Mono-Type Dual80134860292GRIFOLS BRASIL LTDAIV26/06/2033
Anti-H Mono-Type80134860245GRIFOLS BRASIL LTDAIV10/07/2027
Anti-HBc IgM IMMULITE 200010345161621SIEMENS HEALTHCARE DIAGNÓSTICOS LTDAIV14/09/2034
Anti-HBc IgM Reagent Kit10009010504LABTEST DIAGNOSTICA S/AIV29/09/2035
Anti-HBc Reagent Kit10009010463LABTEST DIAGNOSTICA S/AIV21/10/2034
Anti-HBe Reagent Kit10009010462LABTEST DIAGNOSTICA S/AIV21/10/2034
Anti-HBs Reagent Kit10009010471LABTEST DIAGNOSTICA S/AIV21/10/2034
Anti-HCV Reagent Kit10009010469LABTEST DIAGNOSTICA S/AIV21/10/2034
Anti-Jka for DG Gel e Anti-Jkb for DG Gel80134860247GRIFOLS BRASIL LTDAIV10/07/2027
Anti-K (Cellano) Mono-Type80134860243GRIFOLS BRASIL LTDAIV10/07/2027
Anti-K Mono-Type (2)80134860251GRIFOLS BRASIL LTDAIV26/02/2028
Anti-K Mono-Type Dual80134860330GRIFOLS BRASIL LTDAIV16/11/2036
Anti-TP Chemiluminescent Immunoassay Kit82444370479Enzytec Biotecnologia Ltda.IV05/10/2036
Anti-TP Control82444370480Enzytec Biotecnologia Ltda.IV05/10/2036
Anti-Toxoplasma gondii ELISA 2.0 (IgG)10338930339EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV24/11/2035
Anti-Treponema pallidum ELISA 2.0 (IgGM)10338930359EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV10/08/2036
Antibody to Hepatitis B Core Antigen (Anti-HBc)10246810310LABORLAB PRODUTOS PARA LABORATÓRIOS LTDA EPPIV10/12/2028

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家